The third dimension in facial rejuvenation: A review

Journal of Cosmetic Dermatology

Volumn 5, Issue 4, 2006, Pages 277-283

  Donofrio, Lisa ^a,c,d   Weinkle, Susan ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

Aging; Facial volume; Implants; Rejuvenation; Soft tissue fillers; Volume enhancers

Indexed keywords

CALCIUM; COLLAGEN; DIMETICONE; FAT; FILLER; GLUTARALDEHYDE; HYALURONIC ACID; HYDROXYAPATITE; POLYACRYLAMIDE; POLYLACTIC ACID; POLYMER; POLYVINYL ALCOHOL; SILICONE;

AGING; ALLOGRAFT; CUTANEOUS PARAMETERS; FACE PROFILE; FACE SURGERY; HUMAN; INTERMETHOD COMPARISON; LIPOATROPHY; PLASTIC SURGERY; PRIORITY JOURNAL; REVIEW; SKIN SURGERY; SOFT TISSUE; SURGICAL TECHNIQUE;

BIOCOMPATIBLE MATERIALS; COLLAGEN; COSMETIC TECHNIQUES; ESTHETICS; FACE; HUMANS; PROSTHESES AND IMPLANTS; SKIN AGING;

EID: 33751384638     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2006.00270.x     Document Type: Review

References (41)

1. Bettman A. Plastic and cosmetic surgery of the face. Northwest Med 1920; 19: 205.
2. Little JW. Volumetric perceptions in midfacial aging with altered priorities for rejuvenation. Plast Reconstr Surg 2000; 105: 252-66.
3. Werschler WP, Weinkle S. Longevity of effects of injectable products for soft-tissue augmentation. J Drugs Dermatol 2005; 4: 20-7.
4. Pessa JE, Zadoo VP, Mutimer KL et al. Relative maxillary retrusion as a natural consequence of aging: Combining skeletal and soft-tissue changes into an integrated model of midfacial aging. Plast Reconstr Surg 1998; 102: 205-12.
5. Pessa JE, Zadoo VP, Yuan C et al. Concertina effect and facial aging: nonlinear aspects of youthfulness and skeletal remodeling, and why, perhaps, infants have jowls. Plast Reconstr Surg 1999; 103: 635-44.
6. Donofrio LM. Fat distribution: A morphologic study of the aging face. Dermatol Surg 2000; 26: 1107-12.
7. Tan CY, Statham B, Marks R, Payne PA. Skin thickness measurement by pulsed ultrasound: Its reproducibility, validation and variability. Br J Dermatol 1982; 106: 657-67.
8. Gonzalez-Ulloa M, Simonin F, Flores E. The anatomy of the aging face. In: JT Hueston, ed. Transactions of the Fifth International Congress of Plastic and Reconstructive Surgery. London: Butterworth and Co. Ltd; 1971: 1059-66.
9. Hill S. Coming soon. FDA ponders approval of New-fill for wrinkles, volume loss (special report: Soft-tissue augmentation). Dermatology Times 2003; 9: 88.
10. Vleggaar D, Bauer U. Facial enhancement and the European experience with poly-L-lactic acid. J Drugs Dermatol 2004; 3: 526-30.
11. Neuber F. Fettransplantation. Verh Dtsch Ges Chir 1893; 22: 66.
12. Rogers BO. A chronologic history of cosmetic surgery. Bull N Y Acad Med 1971; 47: 265-302.
13. Terino EO. Alloplastic facial contouring by zonal principles of skeletal anatomy. Clin Plast Surg 1992; 19: 487-510.
14. Terino EO. Alloplastic facial contouring: Surgery of the fourth plane. Aesthetic Plast Surg 1992; 16: 195-212.
15. Binder WJ. Submalar augmentation. An alternative to face-lift surgery. Arch Otolaryngol Head Neck Surg 1989; 115: 797-801.
16. Mole B. The use of Gore-Tex implants in aesthetic surgery of the face. Plast Reconstr Surg 1992; 90: 200-6.
17. Binder WJ, Bloom DC. The use of custom-designed midfacial and submalar implants in the treatment of facial wasting syndrome. Arch Facial Plast Surg 2004; 6: 394-7.
18. Constantinides MS, Galli SK, Miller PJ, Adamson PA. Malar, submalar, and midfacial implants. Facial Plast Surg 2000; 16: 35-44.
19. Heidingfield M. Histopathology of paraffin prothesis. J Cutan Dis 1906; 24: 513-21.
20. Cheng JT, Perkins SW, Hamilton MM. Collagen and injectable fillers. Otolaryngol Clin North Am 2002; 35: 73-85.
21. Boss W, Usal H, Chernoff G et al. Autologous cultured fibroblasts: A protein repair system. Ann Plast Surg 2000; 44: 536-42.
22. Tzikas TL. Evaluation of the Radiance FN soft tissue filler for facial soft tissue augmentation. Arch Facial Plast Surg 2004; 6: 234-9.
23. Comite SL, Liu JF, Balasubramanian S, Christian MA. Treatment of HIV-associated facial lipoatrophy with Radiance FN (Radiesse). Dermatol Online J 2004; 10: 2.
24. Matti BA, Nicolle FV. Clinical use of Zyplast in correction of age- and disease-related contour deficiencies of the face. Aesthetic Plast Surg 1990; 14: 227-34.
25. Sengelmann R, Tull S. Dermal fillers (Sood S, ed). Available at: http://www.emedicine.com/derm/topic515.htm. Accessed May 2006.
26. Ramirez OM, Maillard GF, Musolas A. The extended subperiosteal face lift: A definitive soft-tissue remodeling for facial rejuvenation. Plast Reconstr Surg 1991; 88: 227-36.
27. Owsley JQ. Elevation of the malar fat pad superficial to the orbicularis oculi muscle for correction of prominent nasolabial folds. Clin Plast Surg 1995; 22: 279-93.
28. Levan P, Nguyen TH, Lallemand F et al. Correction of facial lipoatrophy in HIV-infected patients on highly active antiretroviral therapy by injection of autologous fatty tissue. AIDS 2002; 16: 1985-7.
29. Donofrio LM. Panfacial volume restoration with fat. Dermatol Surg 2005; 31: 1496-505.
30. Butterwick KJ. Fat autograft muscle injection (FAMI): New technique for facial volume restoration. Dermatol Surg 2005; 31: 1487-95.
31. Gogolewski S, Jovanovic M, Perren SM et al. Tissue response and in vivo degradation of selected polyhydroxyacids: Polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res 1993; 27: 1135-48.
32. Burgess CM, Quiroga RM. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol 2005; 52: 233-9.
33. Valantin MA, Aubron-Olivier C, Ghosn J et al. Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS 2003; 17: 2471-7.
34. Pollack S. Some new injectable dermal filler materials. Hylaform, Restylane, and Artecoll. J Cutan Med Surg 1999; 3 (Suppl. 4): S27-35.
35. Rees T, Ashley F. Treatment of facial atrophy with liquid silicone. Am J Surg 1966; 111: 531-5.
36. Rees T, Ashley F, Delgado J. Silicone fluid injections for facial atrophy. Plast Reconstr Surg 1972; 52: 118-27.
37. Jones DH, Carruthers A, Orentreich D et al. Highly purified 1000-cSt silicone oil for treatment of human immunodeficiency virus-associated facial lipoatrophy: An open pilot trial. Dermatol Surg 2004; 30: 1279-86.
38. Moyle GJ, Lysakova L, Brown S et al. A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med 2004; 5: 82-7.
39. Engelhard P, Humble G, Mest D. Safety of Sculptra ®: A review of clinical trial data. J Cosmet Laser Ther 2005; 7: 201-5.
40. Mest DR, Humble G. Safety and efficacy of intradermal poly-L-lactic acid (Sculptra) injections in patients with HIV-associated facial lipoatrophy. Antivir Ther 2004; 9: L36.
41. Bauer U. Improvement of facial aesthetics at 40 months with injectable poly-L-lactic acid (PLLA). Poster 164. 17th Congress of the International Society of Aesthetic Plastic Surgery in Houston, Texas, August, 2004.